Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

The EU Is Dismissing Public Opposition to Nicotine Taxes as ‘Industry Interference’ Instead of Rethinking Them

February 8, 2026

What Vapers Need to Know

February 8, 2026

What Is THCA Flower? Timing, Labs, and Testing

February 8, 2026
Facebook X (Twitter) Instagram
Monday, February 9
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Insights
  • Home
  • International

    US State Considers Medical Cannabis in Female Orgasm Disorder

    February 5, 2026

    First Placebo-Controlled Trial Finds Cannabis Effective For Migraine

    January 28, 2026

    Using Data for Advanced Access

    January 24, 2026

    The UK’s Cannabis Media Storm

    January 22, 2026

    Europe Medical Cannabis Market Surges Amid Regulatory Reforms

    January 20, 2026
  • News

    Cannabis Culture Can’t Afford to Keep Fighting Itself

    February 8, 2026

    Arkansas Supreme Court Ruling Could Let Lawmakers Roll Back Medical Marijuana Access

    February 8, 2026

    Auravia Medical introduces UK’s first cannabis clinic for NHS waitlist patients

    February 7, 2026

    Who Killed the U.S. Cannabis Market? Blame Canadian Investment Bankers

    February 7, 2026

    Virginia Bill To Allow Medical Marijuana Use In Hospitals Following Federal Rescheduling Advances Toward Senate Floor Vote

    February 6, 2026
  • Lifestyle

    Cannabis, Recovery, and Life in South Dakota

    February 8, 2026

    DEA Promotes Anti-Marijuana PSA Contest Inviting Students To Warn Peers About THC Dangers On 4/20

    February 6, 2026

    The Devil’s Lettuce Wears Prada: Stylist Patricia Field Is Bringing THC to Fashion Week

    February 4, 2026

    Joe Rogan Slams ‘Really Bad’ Federal Hemp Ban Trump Signed, Blaming Alcohol Industry For Influencing Congress

    February 2, 2026

    You’re Not Supposed to Smoke Weed Here. So Why Did This Feel Normal?

    January 31, 2026
  • Law

    Brazil legalizes medical cannabis cultivation, expands patient access

    February 2, 2026

    Florida steps up ‘criminal probe’ of marijuana legalization campaign

    February 1, 2026

    Schedule 3 means new cybersecurity rules for cannabis operators

    January 30, 2026

    Record amount of illicit California cannabis seized in 2025

    January 29, 2026

    Backer of effort to end adult-use marijuana sales in two states revealed

    January 27, 2026
  • Business

    The War on Cannabis Just Moved to the Seeds

    February 8, 2026

    Marijuana Company Sues DoorDash, Total Wine And Others Over Alleged Illegal Sales Of Hemp THC Products

    February 7, 2026

    Bud Bar Displays Designs Trust in the Cannabis Retail Space – Cannabis & Tech Today

    February 5, 2026

    Sherbinskis Was Dying. PrimeTime Took the Risk.

    February 4, 2026

    Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows

    February 2, 2026
  • Education

    What Is THCA Flower? Timing, Labs, and Testing

    February 8, 2026

    How Much Nicotine Is Too Much? Safe Limits Explained

    February 8, 2026

    Cannabis-Infused Drinks Offer Consumers A ‘Harm Reduction’ Alternative To Alcohol, Study Shows

    February 6, 2026

    Do CBD Vapes Make You High? The Science Explained

    February 5, 2026

    Can You Travel with Hemp-Derived THC? What You Need to Know

    February 4, 2026
  • Vaping

    The EU Is Dismissing Public Opposition to Nicotine Taxes as ‘Industry Interference’ Instead of Rethinking Them

    February 8, 2026

    What Vapers Need to Know

    February 8, 2026

    RAZ RX 50K Puff Count Breakdown: What Users Should Know

    February 6, 2026

    Nixamide and Next-Gen Nicotine Replacements

    February 6, 2026

    Germany Proposes Ban on Menthol Vapes Despite Their Proven Effectivity for Smoking Cessation

    February 4, 2026
Smoke Insights
You are at:Home»News»The Hard Truth About Washington and Cannabis Reform: Time, Money, and More Time
News

The Hard Truth About Washington and Cannabis Reform: Time, Money, and More Time

adminBy adminJanuary 18, 2026No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Guest Op-Ed by Gretchen Gailey, President of Project Champion

If there is one lesson the cannabis industry should have learned by now, it’s this: Washington does not run on urgency. It runs on process, power, and patience.

For more than a decade, advocates, entrepreneurs, veterans, patients, investors, and policymakers have been told that federal cannabis reform is just around the corner. One more election. One more committee vote. One more White House signal. And yet, even with the President’s directive to reschedule cannabis to Schedule III, the industry remains in limbo. Businesses are still largely locked out of banking. Patients remain vulnerable. Communities promised equity are still waiting.

The uncomfortable truth is that Washington is working exactly as designed. Change, especially disruptive change, takes time. It takes money. And then it takes more time.

That reality is frustrating. But ignoring it has cost the cannabis industry dearly.

Too often, reform is framed as if moral clarity alone should be enough. As if the injustice of prohibition, overwhelming public support, or the sheer economic scale of cannabis should naturally compel Congress to act. But Washington does not move on righteousness. It moves when incentives align, when pressure is sustained, and when the cost of inaction outweighs the cost of change.

That does not happen overnight.

What’s often missing from the conversation is education, not just public education, but congressional education. Many lawmakers shaping cannabis policy are not experts in the industry, the plant, or the unintended consequences of prohibition. Yet their understanding directly affects how, and whether, reform is implemented. Too often, members rely on cursory staff briefings, outdated assumptions, and legacy narratives that have gone largely unchallenged.

That education gap matters now more than ever as the administration moves toward Schedule III. Without sustained, credible engagement that explains the regulatory, economic, and public health implications of rescheduling, even supportive lawmakers hesitate. And in Washington, hesitation doesn’t just slow progress. It gives agencies cover to delay action.

Major federal reforms, from civil rights to marriage equality to the end of alcohol prohibition, did not succeed because the argument was finally “won.” They succeeded because advocates stayed in the fight long enough to build coalitions, fund serious lobbying operations, educate regulators, neutralize opposition, and survive multiple political cycles without losing momentum.

Cannabis is no different. Pretending otherwise has led to burnout, bad strategy, and misplaced outrage.

The industry has also struggled with a second hard truth: access to Washington is not evenly distributed. Change requires money, not just campaign donations, but sustained investment in policy infrastructure. Experienced lobbyists. Legal expertise. Data. Polling. Relationship-building. Year after year. Administration after administration.

Many cannabis operators understandably resent this reality. The industry already bears enormous costs through punitive taxes, compliance burdens, and legal risk in a state-legal market the federal government still refuses to fully recognize. But refusing to engage with the system as it exists does not make it disappear. It only ensures others, often with competing interests, fill the vacuum.

And those interests are still very much at the table. Law enforcement groups. Pharmaceutical companies. Alcohol distributors. Private prison contractors. They understand Washington’s pace, and they are patient. They show up every day. They fund their priorities relentlessly. And they are content to let cannabis exhaust itself chasing headlines instead of outcomes.

That’s the third hard truth: time favors those who plan for it.

The cannabis movement has won public opinion. It has won the states. It has won the culture. But federal reform is no longer a cultural argument. It is a technical, political, and economic one. Regulatory frameworks. Tax policy. Interstate commerce. Public health standards. Labor protections. Social equity mechanisms that actually function.

None of that fits neatly on a protest sign or in a viral post. But it is where real change happens.

If the industry wants different results, it must adjust its expectations and its tactics. That means committing to long-term advocacy even when progress feels invisible. Supporting sustained efforts between election cycles. Holding allies accountable without burning bridges. Accepting that incremental wins, while unsatisfying, are often the only way forward in a system designed to resist rapid change.

Washington will not be rushed. It will not be shamed into speed. And it will not act simply because cannabis deserves better, no matter how true that may be.

If federal reform is going to move from promise to policy, the industry must invest in the people doing the work where it actually happens. That means supporting the advocates, policy experts, and educators who are in Washington every day briefing staff, engaging agencies, navigating bureaucracy, and telling hard truths when shortcuts won’t work.

Because the reality remains: change takes time, money, and more time. And only those willing to do the work, day in and day out, will shape where cannabis goes next.

This is a guest op-ed by an external contributor. The views expressed are the author’s own and do not necessarily reflect those of High Times.

Source link

cannabis Hard Money Reform time Truth Washington
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleLost Mary MT35000 Turbo Not Working? Fixes & Troubleshooting Guide
Next Article Banks are still refusing cannabis despite Trump marijuana rescheduling
admin

Related Posts

Cannabis, Recovery, and Life in South Dakota

February 8, 2026

The War on Cannabis Just Moved to the Seeds

February 8, 2026

Cannabis Culture Can’t Afford to Keep Fighting Itself

February 8, 2026
Leave A Reply Cancel Reply

Our Picks

The EU Is Dismissing Public Opposition to Nicotine Taxes as ‘Industry Interference’ Instead of Rethinking Them

February 8, 2026

What Vapers Need to Know

February 8, 2026

What Is THCA Flower? Timing, Labs, and Testing

February 8, 2026

How Much Nicotine Is Too Much? Safe Limits Explained

February 8, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Vaping

The EU Is Dismissing Public Opposition to Nicotine Taxes as ‘Industry Interference’ Instead of Rethinking Them

By adminFebruary 8, 20260

Whether it is denial or a blatant attempt to decieve, as the European Union revisits…

What Vapers Need to Know

February 8, 2026

What Is THCA Flower? Timing, Labs, and Testing

February 8, 2026

How Much Nicotine Is Too Much? Safe Limits Explained

February 8, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

The EU Is Dismissing Public Opposition to Nicotine Taxes as ‘Industry Interference’ Instead of Rethinking Them

February 8, 2026

What Vapers Need to Know

February 8, 2026

What Is THCA Flower? Timing, Labs, and Testing

February 8, 2026
Sponsors
Copyright © 2026. SmokeInsights.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.